Selected publications - Nuclear Medicine Research Group

  • Trencsényi, G., Kis, A., Péli-Szabó, J., Ráti, Á., Csige, K., Fenyvesi, É., Szente, L., Malanga, M., Méhes, G., Emri, M., Kertész, I., Vecsernyés, M., Fenyvesi, F., Hajdu, I.: In vivo preclinical evaluation of the new 68Ga-labeled beta-cyclodextrin in prostaglandin E2 (PGE2) positive tumor model using positron emission tomography. Int. J. Pharm. 576 1-35, 2020.
  • Botár, R., Molnár, E., Trencsényi, G., Kiss, J., Kálmán, F., Tircsó, G.: Stable and inert Mn(II)-based and pH responsive contrast agents. J. Am. Chem. Soc. [Epub ahead of print] 1-6, 2020.
  • Forgács, A., Béres, M., Garai, I., Lassen, M., Beyer, T., DiFranco, M., Berényi, E., Balkay, L.: Impact of intensity discretization on textural indices of [18F]FDG-PET tumour heterogeneity in lung cancer patients. Phys. Med. Biol. 64 (12), 1-20, 2019.
  • Balogh, E., Tóth, A., Méhes, G., Trencsényi, G., Paragh, G., Jeney, V.: Hypoxia Triggers Osteochondrogenic Differentiation of Vascular Smooth Muscle Cells in an HIF-1 (Hypoxia-Inducible Factor 1)-Dependent and Reactive Oxygen Species-Dependent Manner. Arterioscler. Thromb. Vasc. Biol. 39 (6), 1088-1099, 2019.
  • Béres, M., Larroza, A., Arana, E., Varga, J., Balkay, L., Moratal, D.: 2D and 3D texture analysis to differentiate brain metastases on MR images: proceed with caution. Magn. Reson. Mat. Phys. Biol. Med. 31 (2), 285-294, 2018.
  • Nagy, G., Szikra, D., Trencsényi, G., Fekete, A., Garai, I., Giani, A., Negri, R., Masciocchi, N., Maiocchi, A., Uggeri, F., Tóth, I., Aime, S., Giovenzana, G., Baranyai, Z.: AAZTA: an Ideal Chelating Agent for the Development of 44Sc PET Imaging Agents. Angew. Chem.-Int. Edit. 56 (8), 2118-2122, 2017.
  • Spisák, T., Pozsgay, Z., Aranyi, C., Dávid, S., Kocsis, P., Nyitrai, G., Gajári, D., Emri, M., Czurkó, A., Kincses, Z.: Central sensitization-related changes of effective and functional connectivity in the rat inflammatory trigeminal pain model. Neuroscience. 344 133-147, 2017
  • Trencsényi, G., Dénes, N., Nagy, G., Kis, A., Vida, A., Farkas, F., Péli-Szabó, J., Kovács, T., Berényi, E., Garai, I., Bai, P., Hunyadi, J., Kertész, I.: Comparative preclinical evaluation of 68Ga-NODAGA and 68Ga-HBED-CC conjugated procainamide in melanoma imaging. J. Pharmaceut. Biomed. Anal. 139 54-64, 2017.
  • Kertész, I., Vida, A., Nagy, G., Emri, M., Farkas, A., Kis, A., Angyal, J., Dénes, N., Péli-Szabó, J., Kovács, T., Bai, P., Trencsényi, G.: In Vivo Imaging of Experimental Melanoma Tumors Using The Novel Radiotracer 68Ga-NODAGA-Procainamide (PCA). J. Cancer. 8 (5), 774-785, 2017.
  • Nagy, G., Dénes, N., Kis, A., Péli-Szabó, J., Berényi, E., Garai, I., Bai, P., Hajdu, I., Szikra, D., Trencsényi, G.: Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific 68 Ga- and 44 Sc-labeled DOTA-NAPamide in melanoma imaging. Eur. J. Pharm. Sci. 106 336-344, 2017.
Last update: 2023. 03. 26. 20:09